ArticleClinical hematology international2022

Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.

Ali Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.